PCR GPW sWIG80 Periodic report · PAP Biznes
PCC Rokita SA (PCR) · Q2 2026 results
Share price: 62.30 zł · 2026-11-10
Results Q2 2026 vs Q2 2025 · year over year · published 19 Aug 2026 and 20 Aug 2025
Net income up 861.6% year on year. The report's language is unchanged.
Only a basic analysis is available for this company at the moment.
1 · Numbers
+861.6%
Net income vs Q2 2025
Net income 79.3M vs 8.2M
Revenue −1.4%
2 · How the report reads
Unchanged
Language tone vs last period
Report language: cautious for a company report — about as upbeat as in Q2 2025.
Weak signal: formal report language, not a call.
3 · What stood out
PCC Rokita SA's annual polioli production will reach 1.3 billion tons.
Read between the lines
No major shifts flagged this period.
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q2 2026. Ring: Q2 2025.
Cautious for a company report — about as upbeat as in Q2 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.
Sentences that drove the tone
“PCC SE Group would experience financial difficulties,”
“Similarly, potentially characterized by lower emissions of volatile compounds, lower interest rates may lead to a decrease in organic costs, a shorter and low-waste production process, and thereby exert a positive impact...”
“digitization by increasing operational efficiency (e.g., an innovation-oriented organizational culture translates into better production planning and optimization of raw material consumption) towards value creation through the development of unique products and faster response...”
Full figures
PLN · PAP Biznes report (2026-08-19)
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | 944.5M | 958.1M | −1.4% |
| Gross profit | 119.0M | 86.3M | +38.0% |
| EBITDA | 178.9M | 118.3M | +51.3% |
| Operating income | 103.0M | 39.2M | +162.8% |
| Net income | 79.3M | 8.2M | +861.6% |
| EPS | 3.91 | 0.42 | +831.0% |
| P/E today 21.0 | 21.3 | 10.1 | +11.2 |
Topics
Topics are drawn from the full report text, not management commentary.
Most discussed now
- Rising The Group's margin in the first half of 2026 amounted to approximately 29%, and realized production in the Chlorinated Derivatives segment…
- At the same time, the relationship between energy prices in Poland and prices in Germany, where they have their installations, is…
- In the period 2026, in addition to its manufacturing and trading activities, the Group was also active in the area of investments.
- Both the Company and the Group's obligations are generally settled in a timely manner, and investment decisions may depend on them in the…
- This is compounded by the unpredictable risk of not receiving payments from counterparties for products and services delivered in different…
Faded since Q2 2025
- Fading For several quarters, chloro-alkali production in Europe has increased by nearly 6% compared to the same period, while it remains under…
- Fading In the case of products from the furniture industry, where CO2 emissions, which have the potential to generate further demand of interest…
- Fading Capital and the Lubricants Complex, given that the criteria for separating a distinct additional reporting segment for municipal waste…
- Fading The Chemicals segment increased sales volume, despite a challenging market situation and renewed competition from China in Europe.
Latest announcements
Official filings, newest first.
- Powołanie Członka Zarządu Spółki · ESPI 23/2026
- Half-year report · ESPI periodic
- Transakcje na akcjach · ESPI 22/2026
- Transakcje na akcjach · ESPI 21/2026
- Zawiadomienie od akcjonariusza Spółki o zakończeniu procesu sprzedaży akcji Spółki w ramach przyspieszonej budowy księgi popytu i wynikach tego procesu · ESPI 20/2026
- Zawiadomienie od akcjonariusza Spółki o rozpoczęciu procesu sprzedaży części posiadanych przez niego akcji Spółki w ramach przyspieszonej budowy księgi popytu · ESPI 19/2026
- Podpisanie listu intencyjnego · ESPI 18/2026
- Rejestracja zmiany statutu emitenta · ESPI 17/2026